Literature DB >> 7384538

Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study.

T J Carty, J D Eskra, J G Lombardino, W W Hoffman.   

Abstract

The new non-steroidal antiinflammatory (NSAI)2 agent, piroxicam [4-hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide], is a highly active inhibitor of prostaglandin (PG) synthesis by methylcholanthrene transformed mouse fibroblasts (MC5-5) and rabbit synovial cells in culture. Comparison of the PG biosynthesis inhibitory activity of piroxicam with other NSAI drugs in these experiments ranks piroxicam as among the most potent agents of this type now known. Some specific modifications of piroxicam's structure result in significant loss in PG synthesis blocking activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7384538     DOI: 10.1016/0090-6980(80)90153-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  11 in total

1.  Comparative studies on the effect of non-steroidal anti-inflammatory drugs (NSAID) on histamine release from mast cells of the rat and guinea pig.

Authors:  J C Gomes; F L Pearce
Journal:  Agents Actions       Date:  1988-07

2.  Gastric bleeding and gastric secretion with sulindac and naproxen.

Authors:  J N Hunt; J L Smith; C L Jiang
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

3.  In vitro study of mediators of inflammation in multiple sclerosis.

Authors:  J E Merrill; S R Strom; G W Ellison; L W Myers
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

4.  Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats.

Authors:  A Mukherjee; V G Hale; O Borga; R Stein
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

Review 5.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

6.  Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam.

Authors:  T J Carty; A Marfat; P F Moore; F C Falkner; T M Twomey; A Weissman
Journal:  Agents Actions       Date:  1993-07

Review 7.  Diverse effects of essential (n-6 and n-3) fatty acids on cultured cells.

Authors:  S I Grammatikos; P V Subbaiah; T A Victor; W M Miller
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

8.  Inhibitory effects of anti-inflammatory drugs on type II collagen induced arthritis in rats.

Authors:  K Yamaki; H Nakagawa; S Tsurufuji
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

9.  Effects of piroxicam on mononuclear cells. Comparison with other antiarthritic drugs.

Authors:  D Gordon; G P Lewis
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

Review 10.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.